Paeds · cardiology
Exercise evaluation and sports participation in heart disease
Also known as Sports participation in heart disease · Preparticipation cardiac screening · Exercise evaluation in the cardiac child · Athlete clearance in congenital and acquired heart disease · Mitchell sport classification · Eligibility and disqualification of the athlete with cardiac disease
Fellowship guide to exercise evaluation and sports participation for the child with heart disease: how to turn the clearance question into a stratified decision built on the cardiac lesion, the haemodynamic load of the sport (Mitchell dynamic x static classification), and the athlete's symptoms and family history; the red-flag exertional history that mandates a 12-lead ECG before clearance; the layered workup from the 14-point history and examination through ECG, echocardiography and cardiopulmonary exercise testing; the three eligibility tiers (cleared, individualised, disqualified) applied across the common substrates from innocent murmurs and repaired simple lesions through bicuspid aortic valve and repaired tetralogy to hypertrophic cardiomyopathy, the channelopathies, anomalous coronary artery and Marfan aortic disease; the AHA/ACC 2015 and ESC 2020 guideline consensus, the Italian ECG-screening evidence, annual re-evaluation of the growing athlete, and venue safety with a written emergency action plan and accessible AED.
On this page
Study tools
Your progress
Saved on this device.
Practise this topic
Target exams
Red flags
- Syncope or chest pain DURING exertion — not after it — is a red flag that halts clearance and mandates a 12-lead ECG and cardiology referral before any return to sport; vasovagal syncope has a prodrome and occurs on standing, never mid-effort
- A family history of sudden unexplained death before age fifty in a first-degree relative demands ECG and specialist assessment before clearance is signed
- Hypertrophic cardiomyopathy, a channelopathy (long-QT, CPVT), an anomalous coronary artery, severe aortic stenosis, and Marfan syndrome with aortic root dilation mean disqualification from competitive sport — do not sign clearance
- The resting ECG and echocardiogram may be normal in the child who collapses on the field; the abnormality is unmasked only by the stress of exertion, which is why exertional symptoms drive the decision, not resting findings
- Every venue where children compete must have a written emergency action plan and an accessible AED; defibrillation within three to five minutes is the single biggest determinant of survival in an athlete cardiac arrest
Life stages
Care settings
Clinical exam formats
Board mappings
- Cardiology
- Preparticipation sports evaluation
- Exercise and the cardiac child
- Paediatric Cardiology — sports participation and eligibility
- General Paediatrics learning goal — recognise the red-flag exertional history
- Stratified clearance and shared decision-making
- Clinical Applications
- Exercise evaluation and sports participation
- Long Cases
- Short Cases
- Communication scenarios
- Cardiology: assesses and counsels the child with cardiac disease on safe exercise and sport
- Syncope and exertional symptoms: distinguishing benign from cardiac causes
- Health promotion: physical activity for the cardiac child
- Foundation of Practice (FOP)
- Applied Knowledge in Practice (AKP)
- Sports participation in heart disease
- Clinical
- History
- Communication
- Preparticipation evaluation and shared decision-making
- General Pediatrics Content Outline — Domain 9: Cardiology
- Subspecialty: Pediatric Cardiology — exercise and sports participation
- Preparticipation screening and sudden cardiac death prevention
- Patient Care 1: History and Physical Examination
- Patient Care 4: Clinical Reasoning
- Medical Knowledge 1: exercise physiology and the cardiac child
- Systems-Based Practice 1: venue safety and emergency action planning
- Medical Expert
- Collaborator
- Health Advocate
- Pediatrics: Core EPA — counsel the family on safe sport participation
Overview & Definition
Picture the fourteen-year-old boy brought to your clinic by his parents because the school rugby coach needs a clearance form signed before the first trial. He has a bicuspid aortic valve picked up years ago on a murmur workup, and his father wants to know whether contact sport is safe. A week later a fifteen-year-old girl sits in front of you after collapsing during a cross-country run — she came around quickly, but her aunt died suddenly at forty-two. Both children are asking the same question, and the answer for each is different. The clearance decision is the whole of this topic: when to say yes, when to individualise, and when the honest answer is that competitive sport is not safe. [1] [2]
Exercise evaluation in heart disease is the structured preparticipation assessment that asks whether a child or adolescent with known or newly suspected cardiac disease can take part in competitive or recreational sport, and at what intensity. The question matters because sport is both a health good — cardiovascular, metabolic, mental-health, and social — and, for a small number of vulnerable hearts, the trigger that unmasks a fatal arrhythmia. The task is to identify that small group without denying rest benefits of exercise. [11] [14]
The decision rests on three legs that you should hold in mind whenever a clearance form arrives. First, the cardiac lesion and its haemodynamic severity: an innocent murmur and a hypertrophic cardiomyopathy are not the same problem. Second, the load of the intended sport, which the Mitchell grid classifies by its dynamic and static intensity. Third, the athlete's own symptoms and family history, which are the strongest predictors of risk and the features most often missed. Hold these three together and the tiered answer — cleared, individualised, or disqualified — usually follows. [1] [10]
References14ShowHide
- [1]Levine BD, Baggish AL, Kovacs RJ, Link MS, Maron BJ Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 1: Classification of Sports: Dynamic, Static, and Impact. J Am Coll Cardiol, 2015.PMID 26542656
- [2]Maron BJ, Levine BD, Washington RL, Baggish AL, Kovacs RJ, Maron MS Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 2: Preparticipation Screening for Cardiovascular Disease in Competitive Athletes. J Am Coll Cardiol, 2015.PMID 26542659
- [3]Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy, and Other Cardiomyopathies. J Am Coll Cardiol, 2015.PMID 26542657
- [4]Van Hare GF, Ackerman MJ, Evangelista JK, Kovacs RJ, Myerburg RJ Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 4: Congenital Heart Disease. J Am Coll Cardiol, 2015.PMID 26542660
- [5]Braverman AC, Harris KM, Kovacs RJ, Maron BJ Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 7: Aortic Diseases, Including Marfan Syndrome. J Am Coll Cardiol, 2015.PMID 26542664
- [6]Thompson PD, Myerburg RJ, Levine BD, Udelson JE, Kovacs RJ Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 8: Coronary Artery Disease. J Am Coll Cardiol, 2015.PMID 26542666
- [7]Zipes DP, Link MS, Ackerman MJ, et al. Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 9: Arrhythmias and Conduction Defects. J Am Coll Cardiol, 2015.PMID 26542670
- [8]Ackerman MJ, Zipes DP, Kovacs RJ, Maron BJ Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 10: The Cardiac Channelopathies. J Am Coll Cardiol, 2015.PMID 26542662
- [9]Link MS, Myerburg RJ, Estes NAM 3rd Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 12: Emergency Action Plans, Resuscitation, Cardiopulmonary Resuscitation, and Automated External Defibrillators. J Am Coll Cardiol, 2015.PMID 26542665
- [10]Pelliccia A, Sharma S, Gati S, Bäck M, Börjesson M, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J, 2021.PMID 32860412
- [11]Longmuir PE, Brothers JA, de Ferranti SD, Hayman LL, McCrindle BW, et al. Promotion of physical activity for children and adults with congenital heart disease: a scientific statement from the American Heart Association. Circulation, 2013.PMID 23630128
- [12]Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, et al. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update. Circulation, 2007.PMID 17353433
- [13]Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA, 2006.PMID 17018804
- [14]Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation, 2009.PMID 19221222